1. Home
  2. BEAM vs MGRC Comparison

BEAM vs MGRC Comparison

Compare BEAM & MGRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Beam Therapeutics Inc.

BEAM

Beam Therapeutics Inc.

HOLD

Current Price

$27.72

Market Cap

2.7B

Sector

Health Care

ML Signal

HOLD

Logo McGrath RentCorp

MGRC

McGrath RentCorp

HOLD

Current Price

$116.55

Market Cap

2.7B

ML Signal

HOLD

Company Overview

Basic Information
Metric
BEAM
MGRC
Founded
2017
1979
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Diversified Commercial Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
2.7B
IPO Year
2019
1995

Fundamental Metrics

Financial Performance
Metric
BEAM
MGRC
Price
$27.72
$116.55
Analyst Decision
Buy
Buy
Analyst Count
12
2
Target Price
$50.75
$141.50
AVG Volume (30 Days)
2.0M
242.5K
Earning Date
05-06-2026
04-29-2026
Dividend Yield
N/A
1.72%
EPS Growth
82.31
N/A
EPS
N/A
6.35
Revenue
$24,000.00
$944,235,000.00
Revenue This Year
N/A
$4.69
Revenue Next Year
$33.77
$4.81
P/E Ratio
N/A
$18.12
Revenue Growth
33.33
3.65
52 Week Low
$15.52
$94.99
52 Week High
$36.44
$128.41

Technical Indicators

Market Signals
Indicator
BEAM
MGRC
Relative Strength Index (RSI) 48.95 60.03
Support Level $25.89 $114.85
Resistance Level $29.06 $117.98
Average True Range (ATR) 1.67 3.96
MACD 0.18 0.11
Stochastic Oscillator 47.35 86.69

Price Performance

Historical Comparison
BEAM
MGRC

About BEAM Beam Therapeutics Inc.

Beam Therapeutics Inc is a biotechnology company committed to creating a new class of precision genetic medicines based on its proprietary base editing technology, with a vision of providing lifelong cures to patients suffering from serious diseases. The company is focused on its programs in the hematology and genetic disease portfolios, which comprise different product candidates in its pipeline, such as BEAM-101, which is being developed to target Sickle Cell Disease, BEAM-302, a liver-targeting lipid nanoparticle, being developed to target Alpha-1 antitrypsin deficiency, and other drug candidates including BEAM-302, BEAM-103 & 104. The company views its operations and manages its business in one operating segment, operating exclusively in the United States.

About MGRC McGrath RentCorp

McGrath RentCorp is a diversified business-to-business rental company with three rental divisions: relocatable modular buildings, portable storage containers, and electronic test equipment. It comprises four reportable business segments, namely the Modular Building segment (Mobile Modular), which generates maximum revenue; the Portable Storage segment (Portable Storage); the Electronic Test Equipment segment (TRS-RenTelco); and its classroom manufacturing business (Enviroplex), which sells modular buildings used as classrooms in California. The company generates its revenues mainly from the rental of its equipment under operating leases, with sales of equipment occurring in the normal course of business.

Share on Social Networks: